EP3060252
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
21.10.2014EP published:
11.12.2019EP application number:
14855074.2
EPO information:
European Patent Register
Max expiry date:
20.10.2034
Title:
USE OF SEMAPHORIN-4D BINDING MOLECULES FOR TREATING NEURODEGENERATIVE DISORDERS
Timeline
Today
21.10.2014EP application
11.12.2019EP Publication
Owner
Name:
Vaccinex, Inc.Address:
1895 Mt. Hope Avenue, Rochester, NY 14620, US
Inventor
Name:
SMITH, Ernest S.Address:
Rochester New York 14610, US
Name:
ZAUDERER, MauriceAddress:
Pittsford New York 14534, US
Name:
BOWERS, William J.Address:
Webster New York 14580, US
Name:
JONASON, AlanAddress:
Pittsford New York 14534, US
Priority
Number:
201361893814 PDate:
21.10.2013Country:
US
Number:
201461979384 PDate:
14.4.2014Country:
US
Number:
201462012805 PDate:
16.6.2014Country:
US
Classification
Categories:
A61K 39/395, A61K 38/00